Smoking and vaping cessation program marketing: USPSTF statements, Medicare counseling and quit claims

A smoking or vaping cessation program can sit inside a primary care practice, a pulmonology or cardiology office, an OB-GYN practice, a behavioral health clinic, a hospital outpatient department or a stand-alone clinic. The people it hopes to reach may have tried to quit before, may feel shame about it, and are wary of anything that sounds like a sales pitch. That makes the marketing simple to describe and easy to get wrong: say what the program involves, who pays for it, and what the evidence supports, and stop there.

Two related topics have their own guides and are not repeated here. Programs for patients with heart or lung disease who need supervised exercise and education are covered in our cardiac and pulmonary rehab marketing guide. Marketing a lung practice as a whole, including lung cancer screening and sleep services, is in our pulmonology practice marketing guide. This guide covers the cessation program itself: how to describe it, how to talk about coverage, which claims need evidence, and how to handle vaping, teens and quitlines. Smoking history also decides who is invited to abdominal aortic aneurysm screening; see AAA screening outreach.

Start with what the USPSTF says, and date it

The U.S. Preventive Services Task Force published its current recommendation on tobacco smoking cessation in adults on January 19, 2021, and its page now carries an “Update in Progress” notice. For nonpregnant adults, the Task Force “recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)-approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.” That is a grade A recommendation. For pregnant persons, the grade A recommendation covers asking, advising and behavioral interventions, and the Task Force says the evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy in pregnancy.

The same statement lists the behavioral interventions it found effective for nonpregnant adults:

• Physician advice and nurse advice.
• Individual counseling with a cessation specialist.
• Group behavioral interventions.
• Telephone counseling.
• Mobile phone based interventions.

Its clinician summary adds that “Combined behavioral counseling and pharmacotherapy includes at least 4 or more behavioral counseling sessions with 90 to 300 minutes of total contact time.” For a program page, this is the backbone. You can describe your program as a series of counseling sessions, say who leads them (a physician, a nurse, a trained counselor), say whether they are one on one, in a group, by phone or by app, and say that medication options are discussed with a clinician who can prescribe. You do not need to name a single drug or brand to do that, and you should not list doses on a marketing page.

Two habits keep this section honest. First, date the recommendation in your copy (“USPSTF, January 19, 2021”) and link it, because an update is in progress and the wording may change. Second, quote the Task Force rather than paraphrasing it into something stronger. “Recommended by the USPSTF” describes counseling and approved medication in general; it does not endorse your clinic, your program format or your results.

Medicare coverage of cessation counseling

Medicare covers tobacco cessation counseling under National Coverage Determination 210.4.1, in chapter 1, part 4 of the Medicare National Coverage Determinations Manual. Coverage applies to outpatient and hospitalized beneficiaries who meet three conditions:

• They use tobacco, whether or not they have signs or symptoms of tobacco-related disease.
• They are competent and alert at the time the counseling is provided.
• The counseling is furnished by a qualified physician or other Medicare-recognized practitioner.

The NCD allows 2 cessation attempts per 12-month period, with up to 4 intermediate or intensive sessions in each attempt, for a total of up to 8 sessions per 12-month period. It defines intermediate sessions as more than 3 minutes but less than 10 minutes, and intensive sessions as more than 10 minutes. It does not cover an inpatient hospital stay when tobacco cessation is the primary reason for the stay. It also notes that Section 4104 of the Affordable Care Act waived the Part B coinsurance and deductible for this service starting January 1, 2011.

The Medicare.gov page for patients says the same thing in plainer words: Part B covers counseling to prevent tobacco use, up to 8 sessions every 12 months, and “You pay nothing if your doctor or other health care provider accepts assignment.” That condition matters. A line such as “Medicare Part B covers up to 8 cessation counseling sessions a year at no cost to you when your provider accepts assignment” is accurate if your clinicians accept assignment. “Free for Medicare patients” without the condition is not something you can print until you have checked it for your billing setup.

Patients with Medicare Advantage, Medicaid, an employer plan or a marketplace plan have their own rules. Your page can say “we check your coverage before your first session” and then do it. If your program has a self-pay option, state the price structure in plain words on the page and in writing before the first visit, rather than in a phone call after the patient has already come in. Our guide on advertising cash prices covers that part.

Vaping: what the evidence and the FDA allow you to say

Vaping shows up in cessation marketing in two ways: as something people want help quitting, and as something sold as a way to quit smoking. The second is where practices get into trouble.

The USPSTF adult statement concludes that “the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons,” and it says “clinicians should direct patients to other cessation interventions with proven effectiveness and established safety.” The FDA page on e-cigarettes and other electronic nicotine delivery systems says products “marketed for therapeutic purposes (for example, marketed as a product to help people quit smoking) are regulated by FDA’s Center for Drug Evaluation and Research.”

Put together, a cessation program should not promote an e-cigarette as a quit aid, should not sell or hand out vaping products, and should not describe switching to vaping as a step in the program. A clinician may talk with an individual patient about their own situation; that is care, not marketing. On your pages, keep to what the USPSTF recommends.

A program that helps people quit vaping is a different matter, and a useful one. You can say you offer counseling for people who want to stop vaping, describe the format, and link Smokefree.gov, which has a section on quitting vaping. What you cannot do is borrow the evidence for adult smoking cessation and present it as proof that your vaping program works. The USPSTF statements cited here were written about tobacco smoking cessation, and the adult statement treats e-cigarettes as a separate question with insufficient evidence.

Teens and young adults need their own care

The USPSTF recommendation on tobacco use in children and adolescents, dated April 28, 2020 and also marked “Update in Progress”, has two parts. It recommends, at grade B, that primary care clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use among school-aged children and adolescents. For school-aged children and adolescents who already use tobacco, it concludes that the evidence is insufficient to assess the balance of benefits and harms of primary care feasible interventions for cessation. It adds that, given that finding, “health care practitioners should determine if offering behavioral counseling for tobacco cessation to certain individuals is reasonable.”

For marketing, that means a teen vaping program can be described, but not sold as proven. Write “counseling for teens who want to stop vaping, with a parent or guardian involved as your practice’s policy and state law allow” rather than “our proven program gets teens off vapes”. Keep teen-facing ads in the voice of a clinic, not a lifestyle brand, and do not use imagery or language that makes vaping look appealing even in a before-and-after frame.

Age also matters for the products themselves. The FDA page says it is illegal for a retailer to sell any tobacco product, including e-cigarettes, to anyone under 21. A practice is not a retailer, but if your program sells any product, including nicotine replacement over the counter, check with counsel how age rules and your state’s rules apply before you list it. Confidentiality rules for minors are also set state by state, so your intake and reminder messages for teens need a policy before the first ad runs. Our pediatric practice marketing guide covers the wider pediatric rules.

Quit claims: one session, hypnosis, laser and success rates

Cessation is a field where outcome claims are easy to write and hard to support. The FTC Act prohibits deceptive acts or practices, 15 U.S.C. 45, and makes it unlawful to disseminate false advertisements for services and devices, 15 U.S.C. 52. The FTC Health Products Compliance Guidance says claims about the health benefits or safety of health-related products “require substantiation in the form of competent and reliable scientific evidence,” and that, “As a general matter, substantiation of health-related benefits will need to be in the form of randomized, controlled human clinical testing.” The guidance looks at each reasonable reading of an ad, including implied claims, and says anecdotal evidence about individual consumer experiences is “never sufficient” to substantiate claims about the effects of a health product.

Claims to drop, or to support with that level of evidence before they run:

• “Quit in one session.”
• “Stop smoking for life.”
• “No cravings, no withdrawal.”
• “Our patients quit at twice the national rate.”
• “Clinically proven” with no study behind the specific program.
• “Doctor recommended” when it means one doctor at your own clinic.

Hypnosis and laser or acupuncture-style programs deserve a direct word. Neither appears in the list of effective behavioral interventions in the USPSTF adult statement quoted above. If you offer them, describe what a session involves, how long it lasts and who delivers it, and do not attach a quit rate, a “proven” label or a money-back promise that implies an outcome. If a patient asks what the evidence shows, a clinician answers that in the room, with the patient’s history in front of them.

Success rates for your own program are a claim like any other. If you publish one, you need to be able to show how it was measured (who was counted, who dropped out, how quitting was confirmed, after how long) and that the number reflects what a new patient can expect. Without that, describe the program and leave the numbers out.

Quitlines: cite them, do not borrow them

The national quitline number is a public resource, and listing it is a kindness to people who are not ready for a clinic visit. Smokefree.gov, managed by the National Cancer Institute’s Tobacco Control Research Branch, says its national quitline number connects callers “directly to your state’s quitline” and that “Hours of operation and services vary from state to state.” The same page also lists a line for support in Spanish and a National Cancer Institute line.

Three rules keep a quitline mention clean. Quote the number exactly as Smokefree.gov gives it and link the page. Do not put your own clinic number next to wording that sounds like a government helpline, and do not call your program “the quitline” or “the official program”. And do not imply that the state or federal program refers patients to you unless it does in writing. Implying an affiliation you do not have is the kind of deception 15 U.S.C. 45 is aimed at.

Programs that also offer low-dose CT screening to current and former smokers have their own rules on eligibility, the shared decision visit and false positives, covered in our guide to lung cancer screening program marketing.

Tobacco use status is health information

A form that asks for cigarettes per day, or whether someone is pregnant and smoking, collects health information. If your practice is a HIPAA covered entity, that information is protected, and sending it, or the fact that someone visited a cessation page and booked, to an ad platform through tracking code can be an impermissible disclosure. Our guide on tracking pixels on practice websites covers what to check. Keep the first form short (name, a way to reach them, best time) and ask clinical questions after the patient is in your system.

Text programs need the same care. If you send quit-day reminders or check-in messages, get the patient’s consent for that channel, keep the content general enough that a message seen on a shared phone does not reveal more than the patient agreed to, and give an easy way to stop. Programs run for an employer raise a further question of who sees what, which our corporate wellness program marketing guide covers.

Stories from former smokers can be powerful, and they are endorsements. A consumer endorsement that conveys a result has to reflect what patients generally achieve, or the ad has to clearly disclose the generally expected results, under 16 CFR 255.2. Anything of value the patient received, such as a free session or a gift card, is a material connection to disclose under 16 CFR 255.5. If you are a covered entity, using a patient’s story or image in marketing requires a written authorization that meets 45 CFR 164.508.

Illustration: two ways to advertise the same program

Illustration: a family medicine practice runs a search ad and a landing page that read “Quit smoking in 30 days or your money back. Our proven program has helped thousands quit for good. Free for Medicare patients. Ask about our vape-to-quit option.” The page has no date on any evidence, a quit form that asks for packs per day before the patient’s name, and a tracking pixel firing on the thank-you page. Every sentence in that ad needs either evidence the practice does not have or a condition it left out.

Illustration: the same practice rewrites it as “Counseling to help you stop smoking or vaping, with a nurse or counselor, in person or by phone. Medication options are discussed with your clinician. Medicare Part B covers up to 8 counseling sessions a year at no cost to you when your provider accepts assignment; we check other coverage before your first visit. Not ready to come in? Call the national quitline listed on Smokefree.gov to reach your state’s quitline.” The page links the USPSTF statement with its date, the Medicare.gov page and Smokefree.gov, the form asks only for a name, a phone number and a good time to call, and no ad pixel runs on the booking pages. Nothing in the second version promises an outcome, and every fact in it can be checked.

Checklist before a cessation campaign goes live

• Program description matches what you deliver: format, who leads it, number of sessions, in person or remote.
• USPSTF statements are quoted, dated and linked, with the update-in-progress notice in mind.
• Medicare wording carries the assignment condition, and other coverage is described as checked case by case.
• No e-cigarette is promoted, sold or described as a quit aid.
• Teen-facing copy describes counseling without calling it proven, and your minor confidentiality policy is set.
• No quit rate, no-cravings or one-session claim runs without competent and reliable scientific evidence.
• Hypnosis, laser or acupuncture offerings are described by what happens in a session, with no outcome attached.
• Quitline numbers are quoted exactly from Smokefree.gov, with no implied government affiliation.
• The first form collects contact details only, and no ad tracking runs on cessation or booking pages.
• Stories have a written authorization, a generally expected results statement and any material connection disclosed.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For a cessation program, that means program pages that quote the USPSTF and Medicare in their own words, search content written around the questions people ask before they are ready to quit, and inquiry forms that keep health information away from tracking tools. We do not decide treatment, coverage or whether a claim is substantiated; your clinicians and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• USPSTF: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (January 19, 2021)
• USPSTF: Tobacco Use in Children and Adolescents: Primary Care Interventions (April 28, 2020)
• CMS: Medicare National Coverage Determinations Manual, chapter 1, part 4, section 210.4.1 (PDF)
• Medicare.gov: Counseling to prevent tobacco use and tobacco-caused disease
• FDA: E-Cigarettes, Vapes, and other Electronic Nicotine Delivery Systems (ENDS)
• Smokefree.gov: Speak to an expert
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 16 CFR 255.5: Disclosure of material connections
• 45 CFR 164.508: Uses and disclosures for which an authorization is required

More in Physician specialty marketing